Baxter International | BAX - Debt


Baxter International reported $9.71B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
AngioDynamics USD 6.3M 6.3M Feb/2025
AtriCure USD 76.73M 521K Sep/2025
Avanos Medical USD 133.7M 3.6M Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 12.05B 19M Sep/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Fresenius EUR 12.85B 778M Jun/2025
Globus Medical USD 119.34M 1.76M Sep/2025
Halozyme Therapeutics USD 1.51B 1.66M Sep/2025
ICU Medical USD 1.28B 79.88M Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 45.8B 4.97B Sep/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 29.1B 491M Sep/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Quest Diagnostics USD 6.38B 2M Sep/2025
Smith & Nephew USD 3.32B 334M Dec/2024
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2B 180.08M Jun/2025
Terumo JPY 159.87B 14.97B Sep/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025